Latest Search
Quote
| Back Zoom + Zoom - | ||||
|
CHINARES PHARMA Surges 10%+ Near 250MA; 2025 Profit Up 21% w/ Final DPS Up 1.3x+
Recommend 0 Positive 1 Negative 1 |
||||
|
||||
|
CHINARES PHARMA (03320.HK) logged a 21% rise in profit last year. The stock price opened 5.17% higher today (25th). With sharper gains, the stock peaked at HKD4.92 in early trading, near the 250MA (HKD4.925). It last posted at HKD4.91, up 10.34%, with a volume of 45.0019 million shares and a turnover of HKD218 million. Last year, CHINARES PHARMA's revenue gained 4.6% YoY to RMB269.574 billion, and net profit grew 20.7% to RMB4.045 billion. The company declared a final DPS of RMB0.122, up approximately 1.35 times YoY. AASTOCKS Financial News Website: www.aastocks.com |
||||
Copied to Clipboard
 |
||||
